Inventaire - your friends and communities are your best library - Inventaire

Brain PET in the diagnosis of Alzheimer's disease

published in: Clinical Nuclear Medicine

date of publication: 2014-10

language: English

main subject: brain, Alzheimer's disease

Cites articles 73

Date

Title

Authors

2014-03

Biological markers of Alzheimer's disease

Leonardo C de Souza, Paulo Caramelli, Antonio L Teixeira
2014-01-01

Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications

Irene Piaceri, Benedetta Nacmias, Sandro Sorbi, Silvia Bagnoli
2014-03-15

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls

Oskar Hansson, Eleftherios P. Diamandis, Lennart Minthon
2014-02-06

Molecular imaging of Alzheimer disease pathology

Kejal Kantarci
2013

Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review
2013-08-01

Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies
2013-12-06

Disease-modifying drugs in Alzheimer's disease

Laura Ghezzi, Daniela Galimberti, Elio Scarpini
2013-10-09

A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: a systematic review

John T. O'Brien
2013-08-14

PET approaches for diagnosis of dementia
2013-04-01

Evolving role of FDG PET/CT in multiple myeloma imaging and management

Ankit Agarwal
2013-01-01

The global prevalence of dementia: a systematic review and metaanalysis

Wagner Ribeiro, Anders Wimo, Cleusa P Ferri, Martin Prince, Emiliano Albanese
2013-10-02

[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease
2013-07-01

Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging.

Maria C Carrillo, Nicolaas I Bohnen
2013-01-01

Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia.
2013-03-01

PET-based primary tumor volumetric parameters and survival of patients with non-small cell lung carcinoma

Gustavo Mercier
2013-01-01

Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline.

Andrew Siderowf, Mark A. Mintun
2012-11-01

PET/CT of cancer patients: part 1, pancreatic neoplasms
2012-06-12

Brain amyloid and cognition in Lewy body diseases

Marta Marquié
2012-05-19

Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapy
2012-01-01

2012 Alzheimer's disease facts and figures
2012-10-10

[(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.

Adrian Smith, Steven E. Arnold, Juha O. Rinne
2012-06-28

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

Eric M. Reiman, Thomas G Beach, Mark A. Mintun, R. Edward Coleman
2012-03-23

Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.

Ronald Boellaard, Albert D. Windhorst, Wiesje van der Flier, Adriaan A Lammertsma, Philip Scheltens, Frederik Barkhof, Rik Ossenkoppele, Bart N M van Berckel, Sofie M Adriaanse, Nelleke Tolboom, Jessica Foster-Dingley, Maqsood Yaqub
2012-03-08

Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease

Gareth R. Jones, Colin L. Masters
2012-02-09

Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand.

Christer Halldin, Anton Forsberg, Lars Farde
2011-01-19

Use of Florbetapir-PET for Imaging β-Amyloid Pathology
2011-04-21

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Bruno Dubois, Peter J. Snyder, Howard Feldman, Nick C. Fox, Dennis W. Dickson, David M. Holtzman, Maria C Carrillo, Ronald C. Petersen, Steven T. DeKosky, William J. Jagust, Creighton H Phelps
2011-08-01

FDG PET/CT in patients with HIV

Timothy Cooley, Gustavo Mercier
2011-07-11

Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology

John Q. Trojanowski, Steven E. Arnold
2011-01-01

Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease
2011-01-01

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

Gareth R. Jones, Kerryn E. Pike, Cassandra Szoeke, Olivier Salvado, William E. Klunk, Kathryn A Ellis, Pierrick Bourgeat, Ralph Martins, Colin L. Masters
2011-10-10

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab.

David J. Brooks, William E. Klunk, Frederik Barkhof

Article - wd:Q27011549

Welcome to Inventaire

the library of your friends and communities

you are offline